GC
IDYA icon

Guggenheim Capital’s IDEAYA Biosciences IDYA Stock Holding History

Guggenheim Capital’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$762K Buy
20,454
+3,361
+20% +$103K ﹤0.01% 1121
2026
Q1 		$570K Buy
17,093
+10,232
+149% +$343K ﹤0.01% 1169
2025
Q4 		$237K Sell
6,861
-23,960
-78% -$764K ﹤0.01% 1627
2025
Q3 		$839K Sell
30,821
-1,716
-5% -$41.5K 0.01% 979
2025
Q2 		$684K Sell
32,537
-2,826
-8% -$54.2K 0.01% 1031
2025
Q1 		$579K Buy
35,363
+3,974
+13% +$84.7K 0.01% 1131
2024
Q4 		$807K Buy
+31,389
New +$889K 0.01% 1011

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Guggenheim Capital's IDYA Position: Q2 2026 in Review

Guggenheim Capital increased its IDEAYA Biosciences (IDYA) stake by 20% in Q2 2026, buying an estimated $103K and bringing the position to 20,454 shares worth $762K. The position accounts for ﹤0.01% of the portfolio, ranked #1121.

Guggenheim Capital first reported a position in IDYA in Q4 2024 and has held it in 7 quarters since. The position peaked at $839K in Q3 2025. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Guggenheim Capital held 20,454 shares of IDEAYA Biosciences worth $762K as of Q2 2026.
  • Guggenheim Capital bought 3,361 IDEAYA Biosciences shares in Q2 2026, an estimated $103K.
  • IDEAYA Biosciences made up ﹤0.01% of Guggenheim Capital's portfolio in Q2 2026, its #1121 holding.
  • Guggenheim Capital first reported a position in IDEAYA Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Guggenheim Capital's IDEAYA Biosciences position peaked at $839K in Q3 2025.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.